NZCurrent Trials
  • Home
  • Clinical Trials
  • Flu Antigen Studies Brisbane TA

Flu Antigen Study

Taringa Brisbane

Please note that this study is now closed. However, we encourage you to pre-register your interest for upcoming flu vaccine trials on our website. 

Description

What to expect

Study details

Ages

18 to 49 years of age

Duration

The study duration is up to 7 months, with up to 8 in clinic visits and 2 telephone calls

Compensation

Participants will be compensated for your time and travel, while supporting medical research

Eligibility Criteria

You may be eligible if you:

  • Are aged 18 to 49 years
  • Are generally healthy
  • Are available to attend scheduled clinic visits
  • Have not previously received an RSV vaccine or an Avian Influenza vaccine (H5)

Other eligibility criteria apply.

Locations

Taringa Brisbane

Description

Respiratory viruses continue to pose a significant challenge to global health. Avian influenza (bird flu) is an infectious disease of birds caused by type A strains like H5 and occurs worldwide. Respiratory Sycytial Virus (RSV) is another  common respiratory virus that can cause serious illness in young children and older adults, Both viruses have the potential to cause severe disease in humans if it emerges more widely in a pandemic.  

Vaccines work by helping the immune system recognise and respond to viruses before illness occurs. New vaccine technologies, including messenger RNA (mRNA) vaccines, are being explored as part of this effort. mRNA vaccines provide the body with instructions to produce a harmless piece of a virus, allowing the immune system to learn how to respond without causing infection.

This clinical research study is evaluating the safety and immune response of investigational mRNA vaccines to better understand how the body responds to different respiratory virus antigens.

This is an early-phase study, and participants are not expected to receive a direct health benefit from taking part. However, the information collected may help researchers better understand how mRNA vaccines targeting different viruses behave in humans and may support the development of future vaccines.

What to expect

Participants will be randomly assigned to receive either the investigational mRNA vaccine with RSV or H5. Depending on the study group, you may receive one or two injections during scheduled clinic visits. 

Throughout the study you will attend regular clinic visits for health assessments, which may include physical examinations, blood tests, and general health checks. These visits help the research team monitor your health and collect important study information. 

Your safety and wellbeing will be closely monitored by our professional clinical team for the duration of the study

Why join this clinical research study?

·         Contribute to important medical research that supports future vaccine development

·         Receive study-related health checks at no cost

·         Be support and monitored by a professional clinical research team

·         Be compensated for your time and travel

Your privacy is important and all personal information will be kept strictly confidential. 

Register your interest today.

Please note that this study is now closed. However, we encourage you to pre-register your interest for upcoming flu vaccine trials on our website. 

Therapeutic AreasClinical TrialsAboutContactCareersNews
ParticipantsSponsors

Australian locations

Sunshine MelbourneTaringa BrisbaneSt Leonards SydneyDarlinghurst Sydney

New Zealand locations

AucklandPukekohe AucklandNorth Auckland

2026 © Momentum Clinical Research

Privacy Policy
West Auckland
Waikato
Tauranga
Rotorua
Palmerston North
Kapiti
Wellington
Hutt Valley
Nelson
Christchurch
Dunedin